MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymthe.2026.05.011

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2026

Costimulatory biomarker-specific CD28 PET for early prediction of the response to PD-1 blockade in lung cancer.

Yang Yang, Wang Jiannan, Yu Hong, Quan Zhen, Zhang Zhujiao, Guo Jingran, Wu Haoxuan, Liu Shanshan, Li Xiaoqian, Hu Xinxin, Zou Hongyan, Zhu Mengyuan, Wang Tianyi, Zhou Zijian, Liu Jiaying, Wang Jing, Wang Kai, Yang Lili, Han Zhaoguo, Sun Xilin

СтатьяПеревод пока не подготовлен

Аннотация

The costimulatory receptor CD28 is indispensable for regulating T cell effector function, and the absence of co-stimulation is associated with poor immunotherapy response. However, longitudinal molecular imaging studies targeting CD28 as a costimulatory biomarker using positron emission tomography (PET) have not been reported. Here, we developed the co-stimulation-associated radiotracer [89Zr]Zr-DFO-anti-CD28 to enable early prediction of therapeutic response by identifying recovery of T cell responsiveness following programmed cell death protein 1 (PD-1) blockade in lung cancer. [89Zr]Zr-DFO-anti-CD28 demonstrated high specificity for CD28+ tumor-infiltrating lymphocytes (TILs) in vitro and in vivo. By monitoring CD28 expression and its loss within the tumor microenvironment, [89Zr]Zr-DFO-anti-CD28 PET identified responses to anti-PD-1 therapy earlier than changes in tumor volume observed at day 5, and increased radiotracer uptake correlated with more favorable treatment responses. Repeated PET imaging was performed to monitor dynamic changes in CD28+ TILs induced by different immunotherapies at day 14, and [89Zr]Zr-DFO-anti-CD28 PET captured the CD28-dependent restoration of T cell effector function, further supporting its potential for early prediction. Taken together, costimulatory biomarker-specific CD28 PET molecular imaging may enable noninvasive early prediction of responses to multiple immunotherapies and facilitate the application of precision medicine in lung cancer.

Для цитирования: Yang Yang, Wang Jiannan, Yu Hong, Quan Zhen, Zhang Zhujiao, Guo Jingran, Wu Haoxuan, Liu Shanshan, Li Xiaoqian, Hu Xinxin, Zou Hongyan, Zhu Mengyuan, Wang Tianyi, Zhou Zijian, Liu Jiaying, Wang Jing, Wang Kai, Yang Lili, Han Zhaoguo, Sun Xilin. Costimulatory biomarker-specific CD28 PET for early prediction of the response to PD-1 blockade in lung cancer.. Molecular therapy : the journal of the American Society of Gene Therapy. 2026. DOI: 10.1016/j.ymthe.2026.05.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.